Known targets — ChEMBL curated mechanism
CHRM1DRD2DRD3DRD4HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR2APDE3ASIGMAR1SLC9A3
The experimentally established mechanism targets of L-Lactic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | CA4 | P22748 | 4/20 | 0.44 |
| ▸ | CA1 | P00915 | 4/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| L-Lactic Acid SCHEMBL6259816 | 0.93 | TP53 (0.44) | TP53CA4CA1CA2CYP3A4 | |
| L-Lactic Acid SCHEMBL5825765 | 0.92 | TP53 (0.50) | TP53CA4CA1CA2CYP3A4 | |
| L-Lactic Acid SCHEMBL22341771 | 0.92 | TP53 (0.50) | TP53CA4CA1CA2CYP3A4 | |
| L-Lactic Acid SCHEMBL2289472 | 0.92 | TP53 (0.50) | TP53CA4CA1CA2CYP3A4 | |
| L-Lactic Acid SCHEMBL975525 | 0.92 | TP53 (0.50) | TP53CA4CA1CA2CYP3A4 | |
| L-Lactic Acid SCHEMBL16395515 | 0.92 | TP53 (0.50) | TP53CA4CA1CA2CYP3A4 | |
| L-Lactic Acid SCHEMBL274590 | 0.92 | TP53 (0.50) | TP53CA4CA1CA2CYP3A4 | |
| L-Lactic Acid SCHEMBL21815670 | 0.92 | TP53 (0.50) | TP53CA4CA1CA2CYP3A4 | |
| L-Lactic Acid SCHEMBL152527 | 0.92 | TP53 (0.50) | TP53CA4CA1CA2CYP3A4 | |
| L-Lactic Acid SCHEMBL9764800 | 0.92 | TP53 (0.50) | TP53CA4CA1CA2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3119386-B1 | A COMPOSITION FOR USE IN THE TREATMENT OF INTERVERTEBRAL DISC-RELATED PAIN | STAYBLE THERAPEUTICS AB (SE) | 2019-06-19 | — | — | EP | claimed |
| US-10322098-B2 | Composition for use in the treatment of intervertebral disc-related pain | STAYBLE THERAPEUTICS AB (SE) | 2019-06-18 | — | — | US | claimed |
| EP-3270908-B1 | A COMPOSITION FOR USE IN THE TREATMENT OF INTERVERTEBRAL MISALIGNMENT | STAYBLE THERAPEUTICS AB (SE) | 2019-04-17 | — | — | EP | claimed |
| US-20180280327-A1 | COMPOSITION FOR USE IN THE TREATMENT OF INTERVERTEBRAL DISC-RELATED PAIN | STAYBLE THERAPEUTICS AB (SE) | 2018-10-04 | — | — | US | claimed |
| US-10080729-B2 | Composition for use in the treatment of intervertebral misalignment | STAYBLE THERAPEUTICS AB (SE) | 2018-09-25 | — | — | US | claimed |
| US-20180169041-A1 | COMPOSITION FOR USE IN THE TREATMENT OF INTERVERTEBRAL DISC-RELATED PAIN | STAYBLE THERAPEUTICS AB (SE) | 2018-06-21 | — | — | US | claimed |
| US-20180071234-A1 | A COMPOSITION FOR USE IN THE TREATMENT OF INTERVERTEBRAL MISALIGNMENT | STAYBLE THERAPEUTICS AB (SE) | 2018-03-15 | — | — | US | claimed |
| EP-3270908-A1 | A COMPOSITION FOR USE IN THE TREATMENT OF INTERVERTEBRAL MISALIGNMENT | STAYBLE THERAPEUTICS AB (SE) | 2018-01-24 | — | — | EP | claimed |
| EP-3119386-A1 | A COMPOSITION FOR USE IN THE TREATMENT OF INTERVERTEBRAL DISC-RELATED PAIN | STAYBLE THERAPEUTICS AB (SE) | 2017-01-25 | — | — | EP | claimed |
| WO-2016150825-A1 | A COMPOSITION FOR USE IN THE TREATMENT OF INTERVERTEBRAL MISALIGNMENT | STAYBLE THERAPEUTICS AB (SE) | 2016-09-29 | — | — | WO | claimed |
| WO-2015140320-A1 | A COMPOSITION FOR USE IN THE TREATMENT OF INTERVERTEBRAL DISC-RELATED PAIN | ENCUBATOR AB (SE) | 2015-09-24 | — | — | WO | claimed |
| WO-2024258867-A1 | SYSTEM AND METHOD FOR PRESERVING ALGAE | Macro Oceans Inc. (US) | 2024-12-19 | — | — | WO | disclosed |
| US-20240409878-A1 | SYSTEM AND METHOD FOR PRESERVING ALGAE | Macro Oceans Inc. (US) | 2024-12-12 | — | — | US | disclosed |
| EP-3119386-B1 | A COMPOSITION FOR USE IN THE TREATMENT OF INTERVERTEBRAL DISC-RELATED PAIN | STAYBLE THERAPEUTICS AB (SE) | 2019-06-19 | — | — | EP | disclosed |
| US-10322098-B2 | Composition for use in the treatment of intervertebral disc-related pain | STAYBLE THERAPEUTICS AB (SE) | 2019-06-18 | — | — | US | disclosed |
| WO-2016150825-A1 | A COMPOSITION FOR USE IN THE TREATMENT OF INTERVERTEBRAL MISALIGNMENT | STAYBLE THERAPEUTICS AB (SE) | 2016-09-29 | — | — | WO | disclosed |
| WO-2015140320-A1 | A COMPOSITION FOR USE IN THE TREATMENT OF INTERVERTEBRAL DISC-RELATED PAIN | ENCUBATOR AB (SE) | 2015-09-24 | — | — | WO | disclosed |
| US-6472079-B2 | PRODUCT OF HYDROLYSIS AND CONDENSATION OF AN ORGANOSILICON COMPOUND; 1A OR 2A COMPOUND, ESPECIALLY CARBOXYLIC SALT; SOLVENT; EXCELLENT CRACKING RESISTANCE AFTER A PCT (PRESSURE COOKER TEST). | JSR CORPORATION (JP) | 2002-10-29 | — | — | US | disclosed |
| US-20020045693-A1 | Composition for film formation, method of film formation and silica-based film | JSR CORPORATION (JP) | 2002-04-18 | — | — | US | disclosed |
| EP-1148105-A2 | Composition for film formation, method of film formation, and silica-based film | JSR Corporation (JP) | 2001-10-24 | — | — | EP | disclosed |